Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of a Rapid Digital PCR Test for the Detection of Non-Small Cell Lung Cancer (NSCLC) Variants.

Molecular diagnosis & therapy·2024
Same author

Analytical Performance and Concordance with Next-Generation Sequencing of a Rapid, Multiplexed dPCR Panel for the Detection of DNA and RNA Biomarkers in Non-Small-Cell Lung Cancer.

Diagnostics (Basel, Switzerland)·2023
Same author

A rapid, multiplex digital PCR assay to detect gene variants and fusions in non-small cell lung cancer.

Molecular oncology·2023
Same author

Social anxiety and interpersonal risk for suicidal ideation: A longitudinal daily diary analysis.

Suicide & life-threatening behavior·2023
Same author

Psychological well-being in US veterans with non-fatal suicide attempts: A multi-cohort population-based study.

Journal of affective disorders·2022
Same author

Motives and Consequences of Alcohol Use in People With Social Anxiety Disorder: A Daily Diary Study.

Behavior therapy·2022

Related Experiment Video

Updated: Jul 4, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K

NSCLC Digital PCR Panel Returns Low-Input Sample Results Where Sequencing Fails.

Leah Rowland Herdt1, Paige Berroteran1, Malini Rajagopalan1

  • 1ChromaCode Inc., 2330 Faraday Ave, Carlsbad, CA 92008, USA.

Diagnostics (Basel, Switzerland)
|February 10, 2024
PubMed
Summary
This summary is machine-generated.

Digital PCR (dPCR) accurately identifies non-small cell lung cancer (NSCLC) mutations in low-input DNA/RNA samples. This method is more sensitive than next-generation sequencing (NGS) for molecular testing in NSCLC patients.

Keywords:
NGSNSCLCQNSdPCR

More Related Videos

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K
Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

12.1K

Related Experiment Videos

Last Updated: Jul 4, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.9K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K
Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

12.1K

Area of Science:

  • Oncology
  • Molecular Diagnostics
  • Genetics

Background:

  • Molecular diagnostics have improved non-small cell lung cancer (NSCLC) survival rates.
  • However, over half of NSCLC patients in the US lack adequate molecular testing.
  • This gap highlights a need for more sensitive and accessible diagnostic methods.

Purpose of the Study:

  • To investigate the relationship between nucleic acid input quantity, molecular testing methodology, and test success rates.
  • To compare the performance of digital PCR (dPCR) and next-generation sequencing (NGS) using low-input samples.
  • To evaluate the accuracy of dPCR for detecting clinically relevant NSCLC mutations.

Main Methods:

  • Utilized a shared set of low-input reference test materials (n=3).
  • Compared a hybrid capture-based NGS assay with a multiplexed dPCR panel.
  • Conducted dilution studies with DNA (1-40 ng) and RNA (2.5-20 ng).
  • Assessed performance on 23 banked clinical samples.

Main Results:

  • dPCR demonstrated high sensitivity and specificity across a wide range of low-input DNA and RNA.
  • NGS exhibited up to an 86% loss in sensitivity with serially diluted samples.
  • dPCR showed high positive predictive agreement (>95%) at low input levels (15/7.5 ng DNA/RNA).

Conclusions:

  • Digital PCR is a sensitive and accurate method for identifying NSCLC mutations, even with limited nucleic acid input.
  • dPCR offers a viable alternative to NGS for molecular testing when sample quality or quantity is a concern.
  • Improving molecular testing accessibility can enhance patient care for NSCLC.